Scinai Immunotherapeutics Ltd
SCNI
$0.90+2.44%
End of day · as of Oct 16, 2026, 8:01 AM ET
Mkt cap
$1.77M
EV/Sales
0.09
P/E ratio
N/A
FY2025 Revenue
$1.31M
EPS (H1 2025)
$-2.10
Gross Margin (FY2025)
-202.29%
Profit Margin (FY2025)
-633.64%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M.
Use this SCNI research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SCNI income, balance, and cash tables.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company in the Healthcare sector.
Latest cached Scinai Immunotherapeutics Ltd (SCNI) revenue for Dec 31, 2025 was $1.3M. Net income was -$8.3M. Statements: https://lician.com/financials/scni
Scinai Immunotherapeutics Ltd (SCNI) market capitalization is $1.8M on the latest cached snapshot.
Scinai Immunotherapeutics Ltd (SCNI) cached previous close $0.88; day range $0.79 – $0.90; volume 365,485. Session quote: https://lician.com/quote/scni
Scinai Immunotherapeutics Ltd (SCNI) latest cached earnings event is "SCNI earnings" on Sep 9, 2026. Earnings calendar: https://lician.com/earnings